Fertility drugs are used to help a person become pregnant and may be used with other fertility treatments, such as in vitro fertilization (IVF). But could these drugs increase a person’s risk for developing cancer? Are they safe to use if you have cancer? Here, learn what the research says about fertility drugs and cancer risk.
Birth control pills have been shown to decrease the risk for certain cancers and increase the risk for others. Here, the current research is summarized on how birth control pills can impact your risk of cancer and questions to ask your doctor if you are taking or considering taking the pill.
In this “Your Stories” podcast from Conquer Cancer, the ASCO Foundation, 2-time cancer survivor Mai Achong discusses the importance of listening to your body and advocating for yourself during cancer, managing fertility concerns, and finding support.
At-home DNA tests have become increasingly popular in recent years. But are they actually helpful for detecting cancer risk? In this post, learn about at-home DNA tests for cancer risk and why it’s always best to get genetic screening done through your health care provider.
In this podcast, Dr. Fay Hlubocky and Dr. Merry Jennifer Markham discuss the unique challenges survivors of gynecologic cancers might face, how to cope with these challenges, and how survivorship care plans can help in the transition from treatment to survivorship.
Dr. Eleonora Teplinsky discusses how the symptoms of menopause can be similar to those of certain types of cancer, what people approaching or going through menopause should know about these symptoms, and how treatment for menopause can impact cancer risk.
ASCO20 Virtual Scientific Program: Effect of Quitting Smoking on Lung Cancer Survival, Maintenance Therapy for Recurrent Ovarian Cancer, Geriatric Assessments, Medicaid Expansion and Overall Cancer Mortality, and Videoconferencing for Caregivers
Read early research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on quitting smoking and lung cancer survival, recurrent ovarian cancer treatment, geriatric assessment for patients receiving systemic therapy, how Medicaid expansion is impacting U.S. cancer mortality, and using videoconferencing with long-distance caregivers.
Programa científico virtual ASCO20: Efecto de dejar de fumar en la supervivencia, un tratamiento para el cáncer de ovario recurrente, evaluaciones geriátricas, expansión de Medicaid y mortalidad por cáncer, y videoconferencia para cuidadores
Lea los puntos destacados iniciales de la investigación del programa científico virtual ASCO20 que se acaban de publicar. Estos incluyen estudios sobre dejar de fumar y la supervivencia al cáncer de pulmón, el tratamiento del cáncer de ovario recurrente, la evaluación geriátrica para los pacientes que están recibiendo terapia sistémica, cómo la ampliación de Medicaid afecta a la mortalidad por cáncer en EE. UU. y el uso de videoconferencias con los cuidadores a distancia.
Dr. Ricardo Cubedo describes 3 research highlights from the ESMO 2019 Congress, including targeted therapy for ovarian cancer, immunotherapy for lung cancer, and more study data on targeted tumor-agnostic treatment.
ASCO Annual Meeting 2019: Treatment Advances for Metastatic Prostate Cancer and Pancreatic Cancer, Multiple Myeloma Survival Factors, and Effects of the Affordable Care Act on Cancer Care
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include an effective medication for metastatic prostate cancer, targeted therapy that slows the growth of metastatic pancreatic cancer, how socioeconomic factors may affect survival for multiple myeloma, and how the ACA resulted in earlier treatment and improved equality in care.